CORRECTED-UPDATE 1-FDA approves Array BioPharma's melanoma combo treatment
June 27, 2018 at 13:40 PM EDT
June 27 (Reuters) - The U.S. Food and Drug Administration (FDA) said on Wednesday it had approved Array BioPharma Inc's oral combination treatment for use in patients with the deadliest form of skin cancer.